Quality of Life in Schizophrenic Patients
NCT00597168 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124
Last updated 2010-06-09
Summary
This is a non-interventional study evaluating quality of life in schizophrenic patients treated with atypical antipsychotics, in the ambulatory setting. This is a 9-month, observational, multicentric prospective study.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Prof Vermylen · UZ Leuven
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2009-10-31
- Completion
- 2009-10-31
Countries
- Belgium
Study Locations
More Related Trials
-
A Non-Interventional Study of Patients With Persistent Symptoms of Schizophrenia to Describe Medical Resource Utilization and Burden of Illness
NCT01959659 ·Status: COMPLETED
-
Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia
NCT01160679 ·Status: COMPLETED
-
Improving Adherence to Oral Antipsychotic Medications in People With Schizophrenia
NCT00406718 ·Status: COMPLETED ·Phase: NA
-
Study of Mental Care in Spain
NCT00824031 ·Status: COMPLETED
-
Morphological, Structural and Functional Neural Substrates of Quality of Life in Schizophrenia
NCT01295411 ·Status: UNKNOWN ·Phase: NA
-
Study on the Efficacy and Safety of QLM1016 in Schizophrenia
NCT06799559 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Antipsychotic Induced Structural and Functional Brain Changes
NCT02435095 ·Status: TERMINATED ·Phase: PHASE4
-
Investigation of Neurophysiological Markers, Possibly Specific of Two Subforms of Psychotic Disorders
NCT03649581 ·Status: RECRUITING ·Phase: NA
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic Setting
NCT00932529 ·Status: COMPLETED ·Phase: PHASE4
-
Interventional Programs' Impact on Patients' Quality of Life and Functioning
NCT06715553 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 ·Status: UNKNOWN
-
A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients
NCT01730768 ·Status: COMPLETED ·Phase: PHASE2
-
Cognition, Functioning and Quality of Life
NCT00182442 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in Schizophrenia
NCT01164059 ·Status: COMPLETED ·Phase: PHASE4
-
Schizophrenic Patients Taking Part in Integrated Care Program
NCT00617214 ·Status: TERMINATED
-
3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis Individuals
NCT02220504 ·Status: COMPLETED ·Phase: NA
-
The Study of Atypical Antipsychotics-induced Metabolic Disturbances
NCT00937755 ·Status: COMPLETED
-
"Multimodal Prevention of Psychosis - Investigating Efficacy of N-Acetylcysteine and Psychotherapy in CHR-Patients"
NCT03149107 ·Status: TERMINATED ·Phase: PHASE3
-
The Treatment Efficacy of Combination Atypical Antipsychotics With Sertraline in Patients With Schizophrenia
NCT04076371 ·Status: COMPLETED ·Phase: NA
-
Response Shift and Quality of Life in Patients Suffering From Schizophrenia and Their Caregivers
NCT02868307 ·Status: UNKNOWN ·Phase: NA
-
Validity of the Spanish Version of Subjective Well-being Under Neuroleptics Scale (SWN-K) in Patients With Schizophrenia
NCT00749970 ·Status: COMPLETED
-
Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers.
NCT03164876 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
NCT04503954 ·Status: COMPLETED ·Phase: NA
-
Assessment of Schizophrenia Patients' Clinical Study Experiences
NCT05948111 ·Status: NOT_YET_RECRUITING